These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 6327962)
21. [Use of cyproheptadine (Peritol) as a drug blocking corticotropin secretion in the treatment of Cushing's syndrome]. Komissarenko IV; Cheban AK; Rybakov SI; Pomerantsev IuV; Slavnov VI Probl Endokrinol (Mosk); 1981; 27(6):39-42. PubMed ID: 6275378 [TBL] [Abstract][Full Text] [Related]
22. [Dynamics of beta-lipotropin and beta-endorphin levels in Itsenko-Cushing disease patients being treated with the antiserotonin preparation cyproheptadine (peritol) and chloditan]. Slavnov VN; Valueva GV; Luchitskiĭ EV Ter Arkh; 1984; 56(9):119-22. PubMed ID: 6096979 [TBL] [Abstract][Full Text] [Related]
23. [Studies on drug therapy of Cushing's syndrome]. Winkelmann W; Fricke U; Hackenberg K; Heesen D; Hoff HG; Hummerich W; Liesen H Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1337-40. PubMed ID: 347777 [No Abstract] [Full Text] [Related]
24. [Criteria for the selection of drugs for the pathogenetic treatment of Itsenko-Cushing disease]. Slavnov VN; Luchitskiĭ EV; Cheban AK Ter Arkh; 1985; 57(12):36-9. PubMed ID: 3003946 [TBL] [Abstract][Full Text] [Related]
25. Direct effects of thyrotropin-releasing hormone, cyproheptadine, and dopamine on adrenocorticotropin secretion from human corticotroph adenoma cells in vitro. Ishibashi M; Yamaji T J Clin Invest; 1981 Oct; 68(4):1018-27. PubMed ID: 6270192 [TBL] [Abstract][Full Text] [Related]
26. [Changes in the secretion of the hormones of the hypothalamo-hypophyseo-adrenal system in Itsenko-Cushing disease under the influence of insulin-induced hypoglycemia and thyroliberin]. Slavnov VN; Luchitskiĭ EV Vrach Delo; 1990 Mar; (3):72-5. PubMed ID: 2164280 [TBL] [Abstract][Full Text] [Related]
27. [Potential use of the antiserotonin preparation cyproheptadine (peritol) in Itsenko-Cushing disease]. Valueva GV; Luchitskiĭ EV; Iakovlev AA Farmakol Toksikol; 1983; 46(2):50-3. PubMed ID: 6852218 [TBL] [Abstract][Full Text] [Related]
28. Sustained remission of Nelson's syndrome after stopping cyproheptadine treatment. Aronin N; Krieger DT N Engl J Med; 1980 Feb; 302(8):453-5. PubMed ID: 6243392 [No Abstract] [Full Text] [Related]
29. Editorial: Cushing's disease: a hypothalamic flush? Feldman JM N Engl J Med; 1975 Oct; 293(18):930-1. PubMed ID: 170520 [No Abstract] [Full Text] [Related]
30. Cushing's disease: failure of treatment with cyproheptadine. Allgrove J; Husband P; Brook CG Br Med J; 1977 Mar; 1(6062):686-7. PubMed ID: 843872 [No Abstract] [Full Text] [Related]
31. Cyproheptadine for Cushing's disease (cont.). Scott R; Espiner EA; Donald RA N Engl J Med; 1977 Jan; 296(1):57-8. PubMed ID: 830282 [No Abstract] [Full Text] [Related]
32. More on cyproheptadine. Tyrrell JB; Brooks RM; Forsham PH N Engl J Med; 1976 Nov; 295(20):1137-8. PubMed ID: 980014 [No Abstract] [Full Text] [Related]
33. Rebound elevation of cortisol following cyproheptadine withdrawal in Cushing's disease from a pituitary macroadenoma. Ooi TC; Twum-Barima Y J Endocrinol Invest; 1987 Apr; 10(2):107-9. PubMed ID: 3584851 [TBL] [Abstract][Full Text] [Related]
40. [Treatment with cyproheptadine of a recurrent case of Cushing's disease]. González LR; Gándara JR Bol Asoc Med P R; 1976 Oct; 68(10):264-6. PubMed ID: 791301 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]